These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

831 related articles for article (PubMed ID: 36069224)

  • 1. [Corrigendum] The novel anti‑neuroblastoma agent PF403, inhibits proliferation and invasion
    Li C; Li Y; Lv H; Li S; Tang K; Zhou W; Yu S; Chen X
    Int J Oncol; 2022 Oct; 61(4):. PubMed ID: 36069224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Corrigendum] SB‑T‑121205, a next‑generation taxane, enhances apoptosis and inhibits migration/invasion in MCF‑7/PTX cells.
    Zheng X; Wang C; Xing Y; Chen S; Meng T; You H; Ojima I; Dong Y
    Int J Oncol; 2023 Jan; 62(1):. PubMed ID: 36484397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Corrigendum] miR‑200b/c targets the expression of RhoE and inhibits the proliferation and invasion of non‑small cell lung cancer cells.
    Tang Q; Li M; Chen L; Bi F; Xia H
    Int J Oncol; 2022 Dec; 61(6):. PubMed ID: 36196896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Corrigendum] ANXA1‑derived peptides suppress gastric and colon cancer cell growth by targeting EphA2 degradation.
    Feng J; Xiao T; Lu SS; Hung XP; Yi H; He QY; Huang W; Tang YY; Xiao ZQ
    Int J Oncol; 2019 Nov; 58(1):133-134. PubMed ID: 33899924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Corrigendum] Adenoviral neutral endopeptidase gene delivery in combination with paclitaxel for the treatment of prostate cancer.
    Iida K; Zheng R; Shen R; Nanus DM
    Int J Oncol; 2024 Nov; 65(5):. PubMed ID: 39301647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Corrigendum] miR‑382 inhibits breast cancer progression and metastasis by affecting the M2 polarization of tumor‑associated macrophages by targeting PGC‑1α.
    Zhou H; Gan M; Jin X; Dai M; Wang Y; Lei Y; Lin Z; Ming J
    Int J Oncol; 2023 Jan; 62(1):. PubMed ID: 36331032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Corrigendum] High expression of FUSE binding protein 1 in breast cancer stimulates cell proliferation and diminishes drug sensitivity.
    Liu W; Xiong X; Chen W; Li X; Hua X; Liu Z; Zhang Z
    Int J Oncol; 2021 Jun; 58(6):. PubMed ID: 33887879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Corrigendum] S100A9 promotes the proliferation and invasion of HepG2 hepatocellular carcinoma cells via the activation of the MAPK signaling pathway.
    Wu R; Duan L; Ye L; Wang H; Yang X; Zhang Y; Chen X; Zhang Y; Weng Y; Luo J; Tang M; Shi Q; He T; Zhou L
    Int J Oncol; 2023 Apr; 62(4):. PubMed ID: 36866758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Corrigendum] CXCR1 promotes malignant behavior of gastric cancer cells
    Wang J; Hu W; Wu X; Wang K; Yu J; Luo B; Luo G; Wang W; Wang H; Li J; Wen J
    Int J Oncol; 2023 Jun; 62(6):. PubMed ID: 37165903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Corrigendum] miR‑593 inhibits proliferation and invasion and promotes apoptosis in non‑small cell lung cancer cells by targeting SLUG‑associated signaling pathways.
    Wei F; Wang M; Li Z; Wang Y; Zhou Y
    Mol Med Rep; 2022 Feb; 25(2):. PubMed ID: 34878153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Corrigendum] Effect of duty cycles of tumor‑treating fields on glioblastoma cells and normal brain organoids.
    Ye E; Lee JE; Lim YS; Yang SH; Park SM
    Int J Oncol; 2022 Sep; 61(3):. PubMed ID: 35894136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Corrigendum] METTL3 antagonizes 5‑FU chemotherapy and confers drug resistance in colorectal carcinoma.
    Li M; Xia M; Zhang Z; Tan Y; Li E; Guo Z; Fang M; Zhu Y; Hu Z
    Int J Oncol; 2023 Sep; 63(3):. PubMed ID: 37503727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Corrigendum] High PLK4 expression promotes tumor progression and induces epithelial‑mesenchymal transition by regulating the Wnt/β‑catenin signaling pathway in colorectal cancer.
    Liao Z; Zhang H; Fan P; Huang Q; Dong K; Qi Y; Song J; Chen L; Liang H; Chen X; Zhang Z; Zhang B
    Int J Oncol; 2021 Jun; 58(6):. PubMed ID: 33955524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Corrigendum] Curcumin reverses benzidine-induced epithelial-mesenchymal transition via suppression of ERK5/AP-1 in SV-40 immortalized human urothelial cells.
    Liu Z; Liu J; Zhao L; Geng H; Ma J; Zhang Z; Yu D; Zhong C
    Int J Oncol; 2023 Jul; 63(1):. PubMed ID: 37326030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Corrigendum] miR-382 inhibits migration and invasion by targeting ROR1 through regulating EMT in ovarian cancer.
    Tan H; He Q; Gong G; Wang Y; Li J; Wang J; Zhu D; Wu X
    Int J Oncol; 2024 Nov; 65(5):. PubMed ID: 39329219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Corrigendum] Downregulation of CD147 induces malignant melanoma cell apoptosis via the regulation of IGFBP2 expression.
    Zhao S; Wu L; Kuang Y; Su J; Luo Z; Wang Y; Li J; Zhang J; Chen W; Li F; He Y; Tao J; Zhou J; Xu X; Peng C; Chen X
    Int J Oncol; 2024 Jan; 64(1):. PubMed ID: 37997849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Corrigendum] The effect of NFATc1 on vascular generation and the possible underlying mechanism in epithelial ovarian carcinoma.
    Li L; Yu J; Duan Z; Dang HX
    Int J Oncol; 2022 Mar; 60(3):. PubMed ID: 35119078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Corrigendum] miR‑23a suppresses pancreatic cancer cell progression by inhibiting PLK‑1 expression.
    Chen B; Zhu A; Tian L; Xin Y; Liu X; Peng Y; Zhang J; Miao Y; Wei J
    Mol Med Rep; 2022 Jul; 26(1):. PubMed ID: 35583007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Corrigendum] Long non‑coding RNA CASC11 interacts with YBX1 to promote prostate cancer progression by suppressing the p53 pathway.
    Sun X; Xin S; Zhang Y; Jin L; Liu X; Zhang J; Mei W; Zhang B; Ma W; Ye L
    Int J Oncol; 2024 Jan; 64(1):. PubMed ID: 38038145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Corrigendum] LRIG2 promotes the proliferation and cell cycle progression of glioblastoma cells
    Xiao Q; Dong M; Cheng F; Mao F; Zong W; Wu K; Wang H; Xie R; Wang B; Lei T; Guo D
    Int J Oncol; 2022 Feb; 60(2):. PubMed ID: 35014687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.